novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enablingscientists and biotech, pharma companies to predict drug efficacy and create the target combination.

AI/ML

Biotechnology

Enterprise Software

Health Care

Information Technology

Novadiscovery

François-Henri Boissel

Simon Arsène

Claudio Monteiro

Lara B.

Alexander Kulesza

Solène Granjeon Noriot

Riad Kahoul

Pierre Beucher

Jean-Pierre Boissel

Fred C.

Emmanuel Pham

Marc Hommel

Ehud Gelblum

Grégoire Boutonnet

Frédéric Cogny

The Leadership Team at Novadiscovery drives the strategic vision and operational execution of the company, focusing on advancing the drug discovery platform for in silico clinical trials. Comprised of co-founders and key executives, this team fosters innovation in mathematics and algorithms to create virtual patient communities, optimizes research and development processes, and enhances partnerships with biotech and pharmaceutical companies to predict drug efficacy and reduce discovery costs.

Leadership Team

Research and Development

Engineering

Leadership Team

About

Team members

Other teams at Novadiscovery

Research and Development

Engineering